FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arzu Ergen

Research Profile

Physiology

Procedures

Geographic Areas

Turkey

Concepts & Ideas

Risk Factors

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
H Arzu Ergen; Ozlem Gök; Umit Zeybek; Zeynep Ermis Karaali
Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus.
Yemliha Yildiz; Soykan Arikan; H Arzu Ergen; Seden Küçücük; Ilhan Yaylim-Eraltan; Turgay Isbir
Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?
Kivanç Bektas-Kayhan; Meral Unür; Ilhan Yaylim-Eraltan; H Arzu Ergen; Bahar Toptas; Günter Hafiz; Ahmet Karadeniz; TURGAY ISBIR
Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arzu Ergen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: H Arzu Ergen; Ozlem Gök; Umit Zeybek; Zeynep Ermis Karaali
Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus.
Biochemia medica : časopis Hrvatskoga društva medicinskih biokemičara / HDMB 2012;22(1):114-20.
2010: Yemliha Yildiz; Soykan Arikan; H Arzu Ergen; Seden Küçücük; Ilhan Yaylim-Eraltan; Turgay Isbir
Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?
Archives of medical science : AMS 2010;6(6):932-6.
2010: Kivanç Bektas-Kayhan; Meral Unür; Ilhan Yaylim-Eraltan; H Arzu Ergen; Bahar Toptas; Günter Hafiz; Ahmet Karadeniz; TURGAY ISBIR
Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma.
In vivo (Athens, Greece) 2010;24(5):755-9.
2010: Ilhan Yaylim-Eraltan; Soykan Arikan; Yemliha Yildiz; Canan Cacina; H Arzu Ergen; Gulay Tuna; Uzay Görmüs; Umit Zeybek; TURGAY ISBIR
The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Anticancer research 2010;30(7):2875-80.
2007: H Arzu Ergen; Uzay Gormus; Fehmi Narter; Umit Zeybek; Sibel Bulgurcuoglu; TURGAY ISBIR
Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Anticancer research 2007;27(6B):4107-10.
2007: H Arzu Ergen; Fehmi Narter; Ozlem Timirci; TURGAY ISBIR
Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: a case-control study.
Anticancer research 2007;27(2):1227-30.
2006: Umit Zeybek; TURGAY ISBIR; H Arzu Ergen; Hulya Yilmaz; Nezih Hekim; Emel Akoglu
Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
Transplantation proceedings 2006;38(5):1382-4.
2005: Bedia Agachan; Hulya Yilmaz; H Arzu Ergen; Zeynep Ermis Karaali; TURGAY ISBIR
Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in turkish patients with type 2 diabetes mellitus.
Physiological research / Academia Scientiarum Bohemoslovaca 2005;54(3):287-93.